Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence

Daniela Cerny, Duyen Huynh Thi Le, Trung Dinh The, Roland Zuest, Srinivasan KG, Sumathy Velumani, Chiea Chuen Khor, Lucia Mori, Cameron P. Simmons, Michael Poidinger, Francesca Zolezzi, Florent Ginhoux, Muzlifah Haniffa, Bridget Wills, Katja Fink

Research output: Contribution to journalLetterResearchpeer-review

3 Citations (Scopus)

Abstract

The family of CD1 molecules is structurally similar to MHC class I molecules, but the 2 protein families mediate fundamentally different immune functions. MHC class I molecules present peptides to T cells, whereas CD1 molecules present lipids to natural killer T cells and other CD1-restricted T cells. CD1a is highly expressed on human Langerhans cells (LCs), a specialized mononuclear phagocyte that is prevalent in the epithelial cell layer of the skin and mucosal surfaces. Epidermal LCs can function as classical antigen-presenting cells (APCs) to induce naive T-cell responses in draining lymph nodes, but also have a regulatory function in the skin via local induction of regulatory T cells and maintenance of epithelial barrier integrity. Human dermal dendriticcells (DCs) also express CD1a, but in much lower amounts compared with LCs. CD1a1 dermal DCs, which coexpress CD1c, have been shown to efficiently stimulate CD41 and CD81 T cells in vitro. However, immune deficiencies due to selective CD1a defects have not been previously described, and it has proved difficult to dissect the specific role of CD1a in immune regulation.
Original languageEnglish
Pages (from-to)1709-1712
Number of pages4
JournalThe Journal of Allergy and Clinical Immunology
Volume138
Issue number6
DOIs
Publication statusPublished - 1 Dec 2016
Externally publishedYes

Cite this